Procrastinator's Marathon 2024 Virtual Program for Pharmacists and Pharmacy Technicians

Dec 15, 2024 Open Pharmacy

Description

This is your last chance to obtain live continuing educational credits for pharmacy license renewal. This knowledge-based continuing education program (offered via Webex) will update the participant regarding Hyperlipidemia, OUD, DVT, Update on New Drugs, and Off Label Use of Migraine Medicine. Don't miss this very relevant information!

Agenda

7:15 AM	Registration/Connect
8:00 AM	Lipid On A Prayer: Current Recommendations for Treating Patients with Hyperlipidemia- Garrett Allegra, PharmD
9:00 AM	The New Era of Opioid Use Disorder- Olivia Caron, PharmD, BCACP, CPP
10:00 AM	Break
10:15 AM	Breaking Down DVT: Tailoring Treatment for Special Populations- Caroline McKenna, PharmD
11:15 AM	Update on New Drugs 2024- Avery Weekman, PharmD
12:15 PM	Break
12:30 PM	When Off Label Makes Good Migraine Medicine- Brian Loftus, MD
1:30 PM	Adjourn

Co-sponsored by:

Target Audience

Pharmacists and Pharmacy Technicians in all aspects of Pharmacy

Objectives

Describe the epidemiology, pathophysiology, and complications of hyperlipidemia (P/PT)
Recognize available treatments for hyperlipidemia and their associated class, mechanism of action, and dosing recommendations (P/PT)
Construct a treatment regimen for a given patient case based on AHA/ACC guideline recommendations (P)
Summarize and compare medications for opioid use disorder (P/PT)
Examine common myths related to the use of buprenorphine and highlight novel induction strategies (P/PT)
Apply non-stigmatizing harm reduction concepts to patient cases (P)
Develop treatment plans for VTE in the context of patient-specific comorbidities (P)
Discuss the importance of monitoring for patient safety, including appropriate lab testing, and s/sx of clotting and bleeding (P)
List 8 medications that were newly approved by the FDA in 2024 (P/PT)
Review the mechanism of action of these medications and their role in their respective disease states (P/PT)
Describe the dosing, precautions, common side effects, and key patient counseling points for these medications (P)
Discuss the myth of triptan overuse headache (P)
Review Topiramate over 100 mg (P)
Review Zonisamide, Duloxetine/Desvenlafaxine, and Candesartan for migraine prevention (P)

Faculty

Garrett Allegra, PharmD
Olivia A. Caron, PharmD, BCACP, CPP
Brian Loftus, MD
Caroline McKenna, PharmD
Avery Weekman, PharmD

Sessions

Procrastinator's Marathon 2024 Virtual Program for Pharmacists and Pharmacy Technicians

12/15 8:00 AM – 1:30 PM

Credits

.500 CEU

The Mountain Area Health Education Center designates this entire live continuing education activity as meeting the criteria for .50 CEUs as established by the National Task Force on the Continuing Education Unit.

5.000 Contact Hours

MAHEC designates this live continuing education activity as meeting the criteria for 5.00 Contact Hours.

5.000 ACPE

The University Of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE program 0046-9999-24-327-L01--P/T provides 5.0 contact hours of continuing pharmacy education credit.

To receive CE credit, participants must verify attendance and complete the evaluation form(s) of this program. Participants must provide their name, email address, NABP e-Profile ID, and date of birth (MMDD) to receive credit. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.

It is the participant's responsibility to check CPE Monitor to verify credit has been uploaded. If credit is not shown, please contact the provider within 60 days of the program date. No partial session credit will be given.

Fees

$89.00 Early Registration Fee- Pharmacists

Applies 11/11/24–12/8/24

$59.00 Early Registration Fee- Pharmacy Techs

Applies 11/11/24–12/8/24

$104.00 Registration Fee- Pharmacists

Applies 12/9/24–12/15/24

$74.00 Registration Fee- Pharmacy Techs

Applies 12/9/24–12/15/24

Brochure / Registration Form